Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| agilon health, inc.AGL · Entity 4698 | Chief Markets Officer | April 14, 2026 | April 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
agilon health, inc.
Report date April 14, 2026 · Filed April 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 123,421 |
Reported balance
After 2026-04-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-04-14 · Tax withholding · Disposed 104 · Balance 123,421 F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. |
| Common StockSEC Table I · non-derivative | Direct | 122,850 |
Reported balance
After 2026-04-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-04-15 · Tax withholding · Disposed 571 · Balance 122,850 F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2: Includes restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
F2: Includes restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2023 Filed May 17, 2023 20:46 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 25,000 | $3.00 | $75,000.00 |
DisclosureSEC source: 0001209191-23-030241 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:46 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 25,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030241 · doc4.xml · derivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,851 Underlying: Common Stock · 25,000 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of September 14, 2021. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:46 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 25,000 | $23.79 | $594,732.50 |
DisclosureSEC source: 0001209191-23-030241 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective September 15, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.43 to $24.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:46 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 25,000 | $3.00 | $75,000.00 |
DisclosureSEC source: 0001209191-23-030241 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 21:35 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 25,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024878 · doc4.xml · derivative · entry 9 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,851 Underlying: Common Stock · 25,000 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of September 14, 2021. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 21:35 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 25,000 | $28.05 | $701,130.00 |
DisclosureSEC source: 0001209191-23-024878 · doc4.xml · nonDerivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective 15 Sept. 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.64 to $28.255, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 21:35 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 25,000 | $3.00 | $75,000.00 |
DisclosureSEC source: 0001209191-23-024878 · doc4.xml · nonDerivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 21:35 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 23,149 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024878 · doc4.xml · derivative · entry 8 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,851 Underlying: Common Stock · 23,149 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of September 14, 2021. Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 21:35 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 1,851 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024878 · doc4.xml · derivative · entry 7 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,851 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of January 12, 2021. Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 21:35 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 1,400 | $28.54 | $39,956.98 |
DisclosureSEC source: 0001209191-23-024878 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,543 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective 15 Sept. 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $28.46 to $28.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 21:35 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 23,600 | $27.70 | $653,639.76 |
DisclosureSEC source: 0001209191-23-024878 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,943 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective 15 Sept. 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.42 to $28.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 21:35 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 23,149 | $3.00 | $69,447.00 |
DisclosureSEC source: 0001209191-23-024878 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 17, 2023 Filed Apr 19, 2023 21:35 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 1,851 | $1.00 | $1,851.00 |
DisclosureSEC source: 0001209191-23-024878 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:51 UTC | agilon health, inc. AGL · Entity 4698 | GrantOptions (Rights to Buy) · Derivative | 37,971 | $0.00 Strike: $28.46 | $0.00 |
DisclosureSEC source: 0001209191-23-024679 · doc4.xml · derivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,971 Underlying: Common Stock · 37,971 shares Expires 2033-04-14 F4 · derivative.exercise_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F4 · derivative.expiration_date: Options that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:51 UTC | agilon health, inc. AGL · Entity 4698 | Tax withholdingCommon Stock | 3,043 | $28.46 | $86,603.78 |
DisclosureSEC source: 0001209191-23-024679 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,543 F3 · shares: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale. F2 · balance_after: Includes restricted stock units. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 20:51 UTC | agilon health, inc. AGL · Entity 4698 | GrantCommon Stock | 21,961 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-024679 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,586 F1 · shares: Restricted stock units that vest in four equal installments on each anniversary of April 14, 2023, subject to continued employment. F2 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:55 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 25,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · derivative · entry 11 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,851 Underlying: Common Stock · 25,000 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of January 12, 2021. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:55 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 10,581 | $26.08 | $275,965.18 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 8 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,625 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $25.98 to $26.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:55 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 9,831 | $25.65 | $252,191.69 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 7 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,206 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.98 to $25.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:55 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 4,588 | $24.36 | $111,741.20 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,037 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.98 to $24.975, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 16, 2023 Filed Mar 17, 2023 20:55 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 25,000 | $1.00 | $25,000.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 25,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · derivative · entry 10 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,851 Underlying: Common Stock · 25,000 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of January 12, 2021. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 70,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · derivative · entry 9 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,306 Underlying: Common Stock · 70,000 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: These options were granted on December 30, 2016, and became fully vested as of January 12, 2021. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 25,000 | $23.80 | $595,075.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,625 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.52 to $24.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 35,000 | $23.81 | $833,231.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,625 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.50 to $24.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 25,000 | $1.00 | $25,000.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:55 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 70,000 | $1.00 | $70,000.00 |
DisclosureSEC source: 0001209191-23-019725 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 22:38 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 28,555 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · derivative · entry 8 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,851 Underlying: Common Stock · 28,555 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of January 12, 2021. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 22:38 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 28,555 | $23.37 | $667,341.77 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · nonDerivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.79 to $23.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 22:38 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 28,555 | $1.00 | $28,555.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:38 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 19,594 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · derivative · entry 7 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,406 Underlying: Common Stock · 19,594 shares Expires 2027-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options were granted on April 27, 2017, and became fully vested as of January 12, 2021. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:38 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 30,406 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,406 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:38 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 50,000 | $22.98 | $1,149,060.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $22.59 to $23.225, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:38 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 19,594 | $1.00 | $19,594.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 22:38 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 30,406 | $3.00 | $91,218.00 |
DisclosureSEC source: 0001209191-23-010205 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 21:28 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 20,723 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004022 · doc4.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,406 Underlying: Common Stock · 20,723 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 21:28 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 20,723 | $19.78 | $409,888.51 |
DisclosureSEC source: 0001209191-23-004022 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.65 to $20.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 18, 2023 Filed Jan 19, 2023 21:28 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 20,723 | $3.00 | $62,169.00 |
DisclosureSEC source: 0001209191-23-004022 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:28 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 25,722 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-23-004022 · doc4.xml · derivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,129 Underlying: Common Stock · 25,722 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:28 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 25,722 | $19.91 | $512,225.34 |
DisclosureSEC source: 0001209191-23-004022 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.59 to $20.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:28 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 25,722 | $3.00 | $77,166.00 |
DisclosureSEC source: 0001209191-23-004022 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:08 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061649 · doc4.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,851 Underlying: Common Stock · 18,750 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:08 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 18,750 | $17.26 | $323,662.50 |
DisclosureSEC source: 0001209191-22-061649 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.99 to $17.58, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 15, 2022 Filed Dec 16, 2022 21:08 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 18,750 | $3.00 | $56,250.00 |
DisclosureSEC source: 0001209191-22-061649 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:08 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-061649 · doc4.xml · derivative · entry 5 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,601 Underlying: Common Stock · 18,750 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:08 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 18,750 | $17.52 | $328,490.63 |
DisclosureSEC source: 0001209191-22-061649 · doc4.xml · nonDerivative · entry 2 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.32 to $18.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 21:08 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 18,750 | $3.00 | $56,250.00 |
DisclosureSEC source: 0001209191-22-061649 · doc4.xml · nonDerivative · entry 1 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 21:50 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionOptions (Right to buy) · Derivative | 18,750 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-22-057871 · doc4.xml · derivative · entry 6 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,351 Underlying: Common Stock · 18,750 shares Expires 2026-12-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on December 30, 2016 and vested on September 14, 2021. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 21:50 UTC | agilon health, inc. AGL · Entity 4698 | SaleCommon Stock | 18,750 | $17.17 | $321,956.25 |
DisclosureSEC source: 0001209191-22-057871 · doc4.xml · nonDerivative · entry 4 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,625 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.60 to $17.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · balance_after: Includes restricted stock units. Read SEC document |
| November 17, 2022 Filed Nov 18, 2022 21:50 UTC | agilon health, inc. AGL · Entity 4698 | Exercise / conversionCommon Stock | 18,750 | $3.00 | $56,250.00 |
DisclosureSEC source: 0001209191-22-057871 · doc4.xml · nonDerivative · entry 3 Shaker Benjamin · CIK 0001855843 · Chief Markets Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.